Skip to content

Clinical trials

Phase 3 Ischemic Stroke trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 3 Country / region: Russia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20141
20151
20171
20182
20191
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pharmasoft2
Supergene, LLC2
Bayer1
CSL Behring1
Clinical Institute of the Brain, Russia1
Materia Medica Holding1
Negovsky Reanimatology Research Institute1
Pierre Fabre Medicament1
Tatchempharmpreparaty, JSC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke11
Stroke6
Brain Ischemia2
Cerebrovascular Disorders2
Acute Coronary Syndrome1
Atherosclerosis1
Atrial Fibrillation1
Cardiovascular Diseases1
Cognitive Dysfunction1
Coronary Artery Disease1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.